Related references
Note: Only part of the references are listed.Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study
Sofia Ramiro et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Chronological reading of radiographs in rheumatoid arthritis increases efficiency and does not lead to bias
Lilian H. D. van Tuyl et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial
Juergen Braun et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis
Xenofon Baraliakos et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort
Sofia Ramiro et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: a longitudinal study
Astrid van Tubergen et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Continuous NSAID use reverts the effects of in ammation on radiographic progression in patients with ankylosing spondylitis
Feline Kroon et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort
Denis Poddubnyy et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis
Denis Poddubnyy et al.
ARTHRITIS AND RHEUMATISM (2012)
The effect of three years of TNF alpha blocking therapy on markers of bone turnover and their predictive value for treatment discontinuation in patients with ankylosing spondylitis: a prospective longitudinal observational cohort study
Suzanne Arends et al.
ARTHRITIS RESEARCH & THERAPY (2012)
ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis
Maxime Dougados et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores
Pedro Machado et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study
Suzanne Arends et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis
C. Lukas et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis
D. van der Heijde et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
The Early Disease Stage in Axial Spondylarthritis Results From the German Spondyloarthritis Inception Cohort
Martin Rudwaleit et al.
ARTHRITIS AND RHEUMATISM (2009)
The Natural Course of Radiographic Progression in Ankylosing Spondylitis - Evidence for Major Individual Variations in a Large Proportion of Patients
Xenofon Baraliakos et al.
JOURNAL OF RHEUMATOLOGY (2009)
Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years
Desiree van der Heijde et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Radiographic Findings Following Two Years of Infliximab Therapy in Patients With Ankylosing Spondylitis
Desiree van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2008)
Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept
D. van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2008)
Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-α antibody infliximab
X. Baraliakos et al.
RHEUMATOLOGY (2007)
Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes
X. Baraliakos et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis
J Braun et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor a antibody infliximab
X Baraliakos et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
What is the most appropriate radiologic scoring method for ankylosing spondylitis?
AJB Wanders et al.
ARTHRITIS AND RHEUMATISM (2004)